These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Predicting five-year outcome for patients with cutaneous melanoma in a population-based study. Barnhill RL, Fine JA, Roush GC, Berwick M. Cancer; 1996 Aug 01; 78(3):427-32. PubMed ID: 8697387 [Abstract] [Full Text] [Related]
7. Sex related survival differences in instances of melanoma. Reintgen DS, Paull DE, Seigler HF, Cox EB, McCarty KS. Surg Gynecol Obstet; 1984 Oct 01; 159(4):367-72. PubMed ID: 6484793 [Abstract] [Full Text] [Related]
8. Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study. Crocetti E, Mangone L, Lo Scocco G, Carli P. Melanoma Res; 2006 Oct 01; 16(5):429-33. PubMed ID: 17013092 [Abstract] [Full Text] [Related]
9. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors. Massi D, Borgognoni L, Franchi A, Martini L, Reali UM, Santucci M. Melanoma Res; 2000 Apr 01; 10(2):153-64. PubMed ID: 10803716 [Abstract] [Full Text] [Related]
11. De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival. Cymerman RM, Shao Y, Wang K, Zhang Y, Murzaku EC, Penn LA, Osman I, Polsky D. J Natl Cancer Inst; 2016 Oct 01; 108(10):. PubMed ID: 27235387 [Abstract] [Full Text] [Related]
12. Prognostic variables for patients with stage III malignant melanoma. Messaris GE, Konstadoulakis MM, Ricaniadis N, Leandros E, Androulakis G, Karakousis PC. Eur J Surg; 2000 Mar 01; 166(3):233-9. PubMed ID: 10755339 [Abstract] [Full Text] [Related]
13. Predicting ten-year survival of patients with primary cutaneous melanoma: corroboration of a prognostic model. Sahin S, Rao B, Kopf AW, Lee E, Rigel DS, Nossa R, Rahman IJ, Wortzel H, Marghoob AA, Bart RS. Cancer; 1997 Oct 15; 80(8):1426-31. PubMed ID: 9338466 [Abstract] [Full Text] [Related]
14. [Malignant melanoma: prognostic evaluation using correlation coefficients]. Kühnl-Petzoldt C, Berger H, Wiebelt H. Hautarzt; 1983 Aug 15; 34(8):398-402. PubMed ID: 6618884 [Abstract] [Full Text] [Related]
15. A prospective population-based study of cutaneous malignant melanoma of the head and neck. Gillgren P, Månsson-Brahme E, Frisell J, Johansson H, Larsson O, Ringborg U. Laryngoscope; 2000 Sep 15; 110(9):1498-504. PubMed ID: 10983950 [Abstract] [Full Text] [Related]
18. Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors. Lindholm C, Andersson R, Dufmats M, Hansson J, Ingvar C, Möller T, Sjödin H, Stierner U, Wagenius G, Swedish Melanoma Study Group. Cancer; 2004 Nov 01; 101(9):2067-78. PubMed ID: 15372475 [Abstract] [Full Text] [Related]
19. Effect of anatomical location on prognosis in patients with clinical stage I melanoma. Rogers GS, Kopf AW, Rigel DS, Friedman RJ, Levine JL, Levenstein M, Bart RS, Mintzis MM. Arch Dermatol; 1983 Aug 01; 119(8):644-9. PubMed ID: 6870318 [Abstract] [Full Text] [Related]
20. Survival of Danish cancer patients 1943-1987. Malignant melanoma of the skin. Osterlind A, Kjems E. APMIS Suppl; 1993 Aug 01; 33():149-55. PubMed ID: 8512737 [Abstract] [Full Text] [Related] Page: [Next] [New Search]